Clinical trial
Effects of Chromium on Insulin Resistance in Alzheimer Disease Patients
NCT03038282 is registered in ClinicalTrials.gov with Metabolic Therapy Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Chromium on Insulin Resistance in Alzheimer Disease Patients
- Lead sponsor
- Metabolic Therapy Inc.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 20, 2017
- Completion date
- October 20, 2019
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.